Showing results (1421-1430 of 1,565) with videos related to

Sort By:
Pageof 157
The Laryngoscope|December 30, 2022
Audiometric and Otologic Findings in Children and Young Adults with Neurofibromatosis Type 1 and Plexiform NeurofibromasVictoria Idowu, Julie Christensen, Andrea M Gross, et al.
HNO|October 17, 2006
[Diagnosis and therapy of auditory synaptopathy/neuropathy]T Moser, N Strenzke, A Meyer, et al.
American Journal of Medical Genetics. Part A|January 24, 2026
Wide Ranging Neurobehavioral Phenotype in Individuals With Costello SyndromeMillicent S Curlee, Atara Siegel, Paige Little, et al.
Virchows Archiv : an International Journal of Pathology|April 1, 2025
Dermatofibrosarcoma protuberans with PDGFD rearrangements: a case series featuring a novel EMILIN1::PDGFD fusion and comprehensive literature reviewSotiris Sotiriou, Kyriakos Chatzopoulos, Gregory W Charville, et al.
American Journal of Medical Genetics|May 30, 2001
Caught in the trio trap? Potential selection bias inherent to association studies using parent-offspring triosT G Schulze, D J Müller, H Krauss, et al.
Plos One|October 17, 2012
Early life stress differentially modulates distinct forms of brain plasticity in young and adult miceInga Herpfer, Henning Hezel, Wilfried Reichardt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 4, 2014
Outcomes from second-line therapy in long-term responders to first-line tyrosine kinase inhibitor in clear-cell metastatic renal cell carcinomaR Elaidi, A Harbaoui, B Beuselinck, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 12, 2005
Pharmacological characterization of CXC chemokine receptor 3 ligands and a small molecule antagonistChristopher E Heise, Anil Pahuja, Sarah C Hudson, et al.
Gut|June 16, 2005
Hereditary non-polyposis colorectal cancer: clinical and molecular evidence for a new entity of hereditary colorectal cancerY Mueller-Koch, H Vogelsang, R Kopp, et al.
European Journal of Cancer (Oxford, England : 1990)|February 10, 2012
Cisplatin alone or combined with gemcitabine in carcinomas of unknown primary: results of the randomised GEFCAPI 02 trialM Gross-Goupil, A Fourcade, E Blot, et al.
Pageof 157